HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Quercetin and doxorubicin co-encapsulated biotin receptor-targeting nanoparticles for minimizing drug resistance in breast cancer.

Abstract
The combination of a chemotherapeutic drug with a chemosensitizer has emerged as a promising strategy for cancers showing multidrug resistance (MDR). Herein we describe the simultaneous targeted delivery of two drugs to tumor cells by using biotin-decorated poly(ethylene glycol)-b-poly(ε-caprolactone) nanoparticles encapsulating the chemotherapeutic drug doxorubicin and the chemosensitizer quercetin (BNDQ). Next, the potential ability of BNDQ to reverse MDR in vitro and in vivo was investigated. Studies demonstrated that BNDQ was more effectively taken up with less efflux by doxorubicin-resistant MCF-7 breast cancer cells (MCF-7/ADR cells) than by the cells treated with the free drugs, single-drug-loaded nanoparticles, or non-biotin-decorated nanoparticles. BNDQ exhibited clear inhibition of both the activity and expression of P-glycoprotein in MCF-7/ADR cells. More importantly, it caused a significant reduction in doxorubicin resistance in MCF-7/ADR breast cancer cells both in vitro and in vivo, among all the groups. Overall, this study suggests that BNDQ has a potential role in the treatment of drug-resistant breast cancer.
AuthorsLi Lv, Chunxia Liu, Chuxiong Chen, Xiaoxia Yu, Guanghui Chen, Yonghui Shi, Fengchao Qin, Jiebin Ou, Kaifeng Qiu, Guocheng Li
JournalOncotarget (Oncotarget) Vol. 7 Issue 22 Pg. 32184-99 (May 31 2016) ISSN: 1949-2553 [Electronic] United States
PMID27058756 (Publication Type: Journal Article)
Chemical References
  • ABCB1 protein, human
  • ATP Binding Cassette Transporter, Subfamily B
  • Drug Carriers
  • Ethylene Glycols
  • Polyesters
  • Receptors, Growth Factor
  • biotin receptor
  • poly(epsilon-caprolactone)-b-poly(ethylene glycol)
  • Biotin
  • Doxorubicin
  • Quercetin
Topics
  • ATP Binding Cassette Transporter, Subfamily B (antagonists & inhibitors, metabolism)
  • Animals
  • Antineoplastic Combined Chemotherapy Protocols (chemistry, metabolism, pharmacology)
  • Biotin (chemistry, metabolism)
  • Breast Neoplasms (drug therapy, metabolism, pathology)
  • Cell Proliferation (drug effects)
  • Cell Survival (drug effects)
  • Dose-Response Relationship, Drug
  • Doxorubicin (chemistry, metabolism, pharmacology)
  • Drug Carriers
  • Drug Compounding
  • Drug Liberation
  • Drug Resistance, Multiple (drug effects)
  • Drug Resistance, Neoplasm (drug effects)
  • Ethylene Glycols (chemistry)
  • Female
  • Humans
  • Kinetics
  • MCF-7 Cells
  • Mice, Inbred BALB C
  • Mice, Nude
  • Nanoparticles
  • Polyesters (chemistry)
  • Quercetin (chemistry, metabolism, pharmacology)
  • Receptors, Growth Factor (metabolism)
  • Solubility
  • Xenograft Model Antitumor Assays

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: